\n\t\t\tKeep abreast of significant corporate, financial and political developments around the world.\n\t\t\tStay informed and spot emerging risks and opportunities with independent global reporting, expert\n\t\t\tcommentary and analysis you can trust.\n\t\t
During your trial you will have complete digital access to FT.com with everything in both of our Standard Digital and Premium Digital packages.
Standard Digital includes access to a wealth of global news, analysis and expert opinion. Premium Digital includes access to our premier business column, Lex, as well as 15 curated newsletters covering key business themes with original, in-depth reporting. For a full comparison of Standard and Premium Digital,Change the plan you will roll onto at any time during your trial by visiting the “Settings & Account” section.
You may also opt to downgrade to Standard Digital, a robust journalistic offering that fulfils many user’s needs. Compare Standard and Premium DigitalAny changes made can be done at any time and will become effective at the end of the trial period, allowing you to retain full access for 4 weeks, even if you downgrade or cancel.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Newspaper headlines: 'Double data breach' and 'Jabs could beat obesity'The news of two major data leaks is among a broad mix of stories to make the front pages on Wednesday.
Consulte Mais informação »
Can CBT help type 2 diabetes and obesity patients implement lifestyle alterations?Can CBT help type 2 diabetes and obesity patients implement lifestyle alterations? SciReports CBT diabetes obesity lifestyle health
Consulte Mais informação »
Eli Lilly/Novo: come for the weight loss, stay for other health benefits\n\t\t\tLet our global subject matter experts broaden your perspective with timely insights and opinions you\n\t\t\tcan’t find anywhere else.\n\t\t
Consulte Mais informação »
Wegovy weight loss drug also cuts risk of heart attack and stroke by 20 per cent, trial shows🔴 The Wegovy weight loss drug reduces the risk of heart attacks and strokes by a fifth for people with obesity, according to the results of a major trial
Consulte Mais informação »
Glasgow woman paralysed after using fake 'skinny pen' to lose weightIn her bid to shed a 'few pounds', Jennifer Clare Finestone invested in a Saxenda pen - which is usually prescribed to people with obesity - but it turned out to be a counterfeit.
Consulte Mais informação »
Wegovy weight loss drug set for use on NHS also cuts heart attack and stroke risk, trial showsA weight-loss jab which could be available on the NHS by the end of the year can also reduce the risk of a heart attack or stroke by 20% Although it is not yet clear when the drug could be approved for such use in the UK PMGallagher1 and BawdenTom
Consulte Mais informação »